Non-Hodgkin's Lymphoma Clinical Trials

• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002461 - Active, not recruiting
  Lymphocytic Lymphoma; Hodgkin's Disease; Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006760 - Active, not recruiting
  recurrent/refractory childhood Hodgkin's lymphoma; childhood lymphocyte predominant Hodgkin's lymphoma; ...
  
• Rituximab in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003820 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma; ...
  
• MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00543582 - Recruiting
  Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma (Follicular or Large Diffuse B-Cell Lymphoma)
  
• Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070304 - Active, not recruiting
  recurrent/refractory childhood Hodgkin's lymphoma; childhood lymphocyte predominant Hodgkin's lymphoma; ...
  
• Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00090038 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Children With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00025064 - Active, not recruiting
  stage II childhood Hodgkin's lymphoma; stage I childhood Hodgkin's lymphoma; stage III childhood Hodgkin's lymphoma; ...
  
• Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082966 - Recruiting
  recurrent adult Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; adult mixed cellularity Hodgkin's lymphoma; ...
  
• Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005985 - Active, not recruiting
  Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma
  
• 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00052442 - Active, not recruiting
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005584 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; adult lymphocyte predominant Hodgkin's lymphoma
  
• Treatment of Non-Hodgkin's Lymphoma with 90Y-hLL2 IgG
  ClinicalTrials.gov Identifier: NCT00061425 - Active, not recruiting
  Non-Hodgkin's Lymphoma; Lymphoma, B-Cell
  
• SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00101244 - Active, not recruiting
  adult Hodgkin's lymphoma; adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; ...
  
• Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00026208 - Recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; ...
  
• Rituxan plus FavId (idiotype vaccine) for Low-grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00041730 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00049595 - Recruiting
  adult lymphocyte depletion Hodgkin's lymphoma; adult mixed cellularity Hodgkin's lymphoma; adult nodular sclerosis Hodgkin's lymphoma; ...
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002522 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002715 - Active, not recruiting
  adult Hodgkin's lymphoma
  
• SDX-105 in Combination with Rituxan for Patients with Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
  ClinicalTrials.gov Identifier: NCT00076349 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Biological Therapy in Treating Patients With Lymphoma or Lymphoproliferative Disease
  ClinicalTrials.gov Identifier: NCT00002663 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma
  
• Autologous Cytotoxic T-Lymphocytes in Treating Patients With Relapsed Epstein-Barr Virus-Associated Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070226 - Recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; primary central nervous system lymphoma; ...
  
• Vaccine Therapy in Treating Patients With Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002821 - Recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Reduced-Intensity Regimen Before Allogeneic Bone Marrow Transplantation in Treating Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00057954 - Active, not recruiting
  adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00086801 - Active, not recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma
  
• Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00060385 - Active, not recruiting
  adult T-cell leukemia and lymphoma; Cutaneous T-Cell Lymphoma; Non-Hodgkin's Lymphoma
  
• Long-Term Effects of Iodine I131 Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00098566 - Active, not recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma; Quality of Life
  
• Study of CMC-544 Administered as a Single Agent in Subjects With B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00073749 - Active, not recruiting
  Lymphoma, Non-Hodgkin's; B-Cell Lymphoma
  
• Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00058305 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00001337 - Recruiting
  Non Hodgkin's Lymphoma
  
• Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Pegfilgrastim Compared With Filgrastim To Increase Peripheral Stem Cells Before Autologous Stem Cell Transplantation in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00060229 - Active, not recruiting
  adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma; Cutaneous T-Cell Lymphoma
  
• Tipifarnib in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082888 - Recruiting
  adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; ...
  
• Surgery and/or Combination Chemotherapy With or Without Radiation Therapy or Observation Only in Treating Young Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00107198 - Recruiting
  childhood lymphocyte predominant Hodgkin's lymphoma; stage I childhood Hodgkin's lymphoma; stage II childhood Hodgkin's lymphoma
  
• Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003631 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma
  
• Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00087009 - Recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma
  
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003389 - Active, not recruiting
  adult Hodgkin's lymphoma
  
• Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00052416 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Chemotherapy for Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00090727 - Active, not recruiting
  Solid Malignancies; Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00041210 - Recruiting
  adult Hodgkin's lymphoma
  
• Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients
  ClinicalTrials.gov Identifier: NCT00081783 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Radiolabeled Monoclonal Antibody Therapy in Treating Adult Patients Who Have Recurrent Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00019305 - Recruiting
  Lymphoma; Radiation Toxicity
  
• Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab
  ClinicalTrials.gov Identifier: NCT00240578 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Vinblastine, Cyclophosphamide, Procarbazine, Prednisolone, Etoposide, Mitoxantrone, and Bleomycin in Treating Older Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00079105 - Recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma
  
• Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00345865 - Recruiting
  Leukemia; Lymphoma
  
• Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00359892 - Active, not recruiting
  Hodgkin's Lymphoma
  
• Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00028717 - Active, not recruiting
  adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; grade 3 follicular lymphoma; Mantle Cell Lymphoma
  
• A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00201669 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00007865 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00091091 - Recruiting
  long-term effects secondary to cancer therapy in children; stage I childhood Hodgkin's lymphoma; stage II childhood Hodgkin's lymphoma; ...
  
• A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00269113 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00547534 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade non-Hodgkin's Lymphoma Following First Line CHOP
  ClinicalTrials.gov Identifier: NCT00022932 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00341952 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00006042 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• A Study of SB-743921 in Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00343564 - Recruiting
  Non-Hodgkin's Lymphoma; Hodgkin's Disease
  
• Oblimersen and Rituximab in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00054639 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00052936 - Recruiting
  adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Non-Hodgkin's Lymphoma
  
• A Study of Oral LY317615 in Relapsed or Refractory Diffuse Large B-Cell Lymphomas.
  ClinicalTrials.gov Identifier: NCT00042666 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005613 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Combination Chemotherapy and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00057772 - Recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002941 - Active, not recruiting
  recurrent childhood lymphoblastic lymphoma; childhood diffuse large cell lymphoma; childhood immunoblastic large cell lymphoma; ...
  
• High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003116 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ...
  
• CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00084474 - Recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00008164 - Active, not recruiting
  Langerhans cell histiocytosis; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer
  
• Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
  ClinicalTrials.gov Identifier: NCT00240591 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Bortezomib and Fludarabine in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00068315 - Recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Bortezomib in Treating Patients With Lymphoproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00023764 - Recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00072488 - Recruiting
  Ewing's family of tumors; childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; childhood rhabdomyosarcoma; Neuroblastoma
  
• Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00022893 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma That Has Not Responded to Previous Treatment
  ClinicalTrials.gov Identifier: NCT00014209 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ...
  
• Iodine I 131 Tositumomab and Fludarabine in Treating Older Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00110071 - Recruiting
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
  
• MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
  ClinicalTrials.gov Identifier: NCT00059995 - Active, not recruiting
  recurrent adult Hodgkin's lymphoma; recurrent/refractory childhood Hodgkin's lymphoma; anaplastic large cell lymphoma; ...
  
• Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00055653 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases
  
• Monoclonal Antibody Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00017381 - Recruiting
  adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004171 - Active, not recruiting
  recurrent adult diffuse small cleaved cell lymphoma; recurrent grade III follicular large cell lymphoma; ...
  
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00003913 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; myelodysplastic and myeloproliferative diseases
  
• Phase II study of ONTAK in previously treated patients with low-grade Non-Hodgkin's Lymphoma (NHL)
  ClinicalTrials.gov Identifier: NCT00051025 - Recruiting
  Non-Hodgkin's Lymphoma; Lymphoma, B-Cell; Lymphoma, Low-Grade
  
• A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00452127 - Recruiting
  Non-Hodgkin's Lymphoma
  
• phII Study of an HDAC Inhibitor in Very High-Risk Relapsed/Refractory Hodgkin's Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00496431 - Recruiting
  Hodgkin's Lymphoma
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
  ClinicalTrials.gov Identifier: NCT00006379 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Gastrointestinal Cancer; hematopoietic and lymphoid cancer
  
• Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00201877 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00238433 - Recruiting
  Lymphoma
  
• Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00354926 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Study of Bexxar Combined With External Beam Radiation Therapy for Patients With Relapsed, Bulky Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00490490 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Safety and Efficacy of Campath in Nonmyeloablative Transplantation
  ClinicalTrials.gov Identifier: NCT00038844 - Active, not recruiting
  Non Hodgkin's Lymphoma; Hodgkin's Disease; Chronic Lymphocytic Leukemia
  
• Omeprazole and Bortezomib in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00107302 - Recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00312845 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00358982 - Recruiting
  Hodgkin's Lymphoma
  
• Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00441818 - Recruiting
  Hodgkin's Lymphoma
  
• Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00250861 - Active, not recruiting
  Non-Hodgkin's Lymphoma
  
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003150 - Completed
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers
  ClinicalTrials.gov Identifier: NCT00003658 - Active, not recruiting
  adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Combination Chemotherapy Followed by Donor Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Genetic Disorders
  ClinicalTrials.gov Identifier: NCT00008307 - Active, not recruiting
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm
  
• A Study of Fission-Derived Iodine I 131 Tositumomab (Bexxar) for Patients With Previously Untreated or Relapsed Follicular or Transformed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00315731 - Recruiting
  Non-Hodgkin's Lymphoma; Follicular Lymphoma; Diffuse Large Cell Lymphoma; Transformed Diffuse Large Cell Lymphoma
  
• Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00185757 - Recruiting
  Non-Hodgkin's Lymphoma; Hodgkin's Lymphoma; Multiple Myeloma
  
• Tailoring Treatment for B Cell Non-Hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
  ClinicalTrials.gov Identifier: NCT00324467 - Recruiting
  Lymphoma, Non-Hodgkin; Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
  
• Elsamitrucin (SPP 28090) in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00184080 - Recruiting
  Non-Hodgkin's Lymphoma
  
• VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00045266 - Active, not recruiting
  adult non-Hodgkin's lymphoma; adult solid tumor